Titterton Lewis H jr — SEC Form 4 filings
SEC reporting owner CIK 1499254. 30 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2024-01-16 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 22 legs across 18 filings — 4,903,844 shares, $1,421,561 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: purchase of 4,761,905 shares @ $0.21 ($1,000,000) in PARKERVISION INC, filed 2025-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PARKERVISION INC (PRKR) | Director | 8 | 1 leg · 4,761,905 sh · $1,000,000 | — | 18 |
| Anixa Biosciences Inc (ANIX) | Director | 22 | 21 legs · 141,939 sh · $421,561 | — | 7 |
Form 4 filings — Titterton Lewis H jr
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $2.73 | EDGAR |
| 2026-07-20 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 12,000 @ $3.47 | EDGAR |
| 2026-07-16 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,797 @ $3.28 | EDGAR |
| 2026-06-17 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,836 @ $2.64 | EDGAR |
| 2026-01-26 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 370,000 (derivative) @ $0.24 | EDGAR |
| 2026-01-06 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 16,000 @ $2.92 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | PARKERVISION INC (PRKR) | Purchase (P): 4,761,905 @ $0.21 | EDGAR |
| 2025-10-07 | 4 | PARKERVISION INC (PRKR) | Option exercise (M): 525,000 @ $0.18 · Option exercise (M): 275,000 @ $0.20 · Option exercise (M): 525,000 (derivative) @ $0.18 · Option exercise (M): 275,000 (derivative) @ $0.20 | EDGAR |
| 2025-08-04 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $3.08 | EDGAR |
| 2025-07-15 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $3.14 | EDGAR |
| 2025-07-08 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 275,000 | EDGAR |
| 2025-05-09 | 4 | PARKERVISION INC (PRKR) | Conversion (C): 1,699,844 @ $0.13 · Conversion (C): 1,699,844 (derivative) @ $0.13 | EDGAR |
| 2025-01-27 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,000 @ $2.91 · Purchase (P): 1,000 @ $3 | EDGAR |
| 2025-01-23 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,000 @ $3.01 | EDGAR |
| 2025-01-22 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 6,000 @ $2.59 | EDGAR |
| 2025-01-17 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $2.57 | EDGAR |
| 2025-01-07 | 4 | PARKERVISION INC (PRKR) | Gift (G): 2,000,000 @ $0 | EDGAR |
| 2025-01-03 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 16,000 @ $2.58 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2024-09-25 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 29,413 @ $0.17 · Grant/award (A): 8,568 @ $0.17 · Conversion (C): 257,370 @ $0.10 · Conversion (C): 514,740 @ $0.10 · Conversion (C): 405,524 @ $0.13 · Conversion (C): 257,370 (derivative) @ $0.10 · +2 more | EDGAR |
| 2024-08-01 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 21,646 @ $3.06 · Purchase (P): 5,580 @ $3.23 | EDGAR |
| 2024-07-29 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 796 @ $2.81 · Purchase (P): 7,700 @ $3.03 | EDGAR |
| 2024-06-18 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 4,000 @ $2.68 | EDGAR |
| 2024-06-14 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 405 @ $2.70 | EDGAR |
| 2024-06-12 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 330 @ $2.60 · Purchase (P): 7,102 @ $2.66 | EDGAR |
| 2024-06-10 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,738 @ $2.52 | EDGAR |
| 2024-04-10 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 15,009 @ $3.28 | EDGAR |
| 2024-02-05 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 275,000 (derivative) @ $0.20 | EDGAR |
| 2024-01-16 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1499254 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →